Wednesday, December 30, 2020
  1. Global age-sex-specific mortality, life expectancy, and population estimates in 204 countries and territories and 811 subnational locations, 1950–2021, and the impact of the COVID-19 pandemic: a comprehensive demographic analysis for the Global Burden of Disease Study 2021. Click here
  2. Pathan A. Limitations of Alzheimer’s Disease Medications NeuroPharmac Journal. 2023;8(3):11-17. Click here
  3. Global, regional, and national burden of rheumatoid arthritis, 1990-2020, and projections to 2050: a systematic analysis of the Global Burden of Disease Study 2021. Lancet Rheumatol. 2023 Sep 25;5(10):e594-e610. Click here
  4. Global, regional, and national incidence of six major immune-mediated inflammatory diseases: findings from the global burden of disease study 2019. EClinicalMedicine. 2023 Sep 9;64:102193. Click here
  5. Pathan A. Stroke and migraine are leading neurological conditions on a global scale NeuroPharmac Journal. 2023; (08): 1-2. Click here
  6. Pathan A, Logade N, Khan F. Neurological adverse effects after SARS-CoV-2 vaccinations: Etiology should be warranted NeuroPharmac Journal. 2023; (08): 1-5. Click here
  7. Farag M, Pathan A, Aldoij N. Interaction between anti-COVID compounds across spike protein subunits influences their inhibition potential. Ann. Phytomed. 2023; 12(1):1-8. Click here
  8. Farag M, Pathan A, Aldoij N. Molecular docking analysis of ten plant products for the inhibition of spike glycoprotein and prospective use as anti-COVID compounds. Ann. Phytomed. 2022;11(2):302-308. Click here
  9. Alenazi F, Pathan A. Neuropharmacology of Levetiracetam as Anti-epileptic Medication. NeuroPharmac Journal. 2022; (12): 1-6. Click here
  10. AE Peden, P Cullen, KL Francis, H Moeller, MM Peden, Pathan A. Adolescent Transport and Unintentional Injuries Collaborators. Adolescent transport and unintentional injuries: a systematic analysis using the Global Burden of Disease Study 2019. Lancet Public Health. 2022;7(8):e657-e669. Click here
  11. Farag M, Pathan A. Aldoaij N. Literature review of 10 plants products for their anti-inflammatory, antioxidant, immunomodulatory, and antiviral properties. NeuroPharmac Journal. 2021; (12): 241-247. Click here
  12. Pathan A. Neurological complications and COVID-19: A literature review NeuroPharmac Journal. 2021;(04): 142-144. Click here
  13. Alshahrani A, Jamal Y, Almarshad F, Pathan A, Arif J. Correlation of COVID-19 with Parkinson’s disease and life expectancy indicates female population predominance in future. Annals of Phytomedicine-an International Journal; 10(1): S13-S21, 2021. Click here
  14. Bilal Ahamad Paray, Aqeel Ahmad, Javed Masood Khan, Faisal Taufiq, Aslam Pathan, Ajamaluddin Malik, Mohammad Z. Ahmed, The role of the multifunctional antimicrobial peptide melittin in gene delivery, Drug Discovery Today, 2021, https://pubmed.ncbi.nlm.nih.gov/33450177/
  15. Pathan A. Alshahrani A. Almarshad F. COVID-19 in the Shaqra, Saudi Arabia: prevalence and prevention strategies. NeuroPharmac J. 2020; 5(3): 131- 134. https://doi.org/10.37881/1.531
  16. Almujalli AA, Almatrafi AA, Aldael AA, Almojali HA, Almujalli AI, Pathan A. Knowledge, attitude, and practice about myopia in school students in Marat city of Saudi Arabia. J Family Med Prim Care 2020;9:3277-80 https://pubmed.ncbi.nlm.nih.gov/33102283/
  17. Pathan A. Lamotrigine and Phenytoin indicated for epilepsy recalled by the manufacturer in America. NeuroPharmac J. 2020;5(1):118-120. https://doi.org/10.37881/1.513
  18. Pathan A. Urgent health challenges for the next decade 2030: World Health Organization. NeuroPharmac J. 2020;5(1):113-117. https://doi.org/10.37881/1.512
  19. Pathan A. Current off-label Pharmacotherapeutics in the management of novel coronavirus disease (COVID-19). NeuroPharmac J. 2020;5(1):108-112. https://doi.org/10.37881/1.511
  20. Pathan A. Top Pharma companies not following current good manufacturing processes: Angiotensin II receptor blockers with carcinogenic impurities: A threat to global public health. NeuroPharmac J. 2019;4(3):105-107. https://doi.org/10.37881/1.432
  21. Pathan A. FDA recalled Ranitidine: What about the consumers who ate Ranitidine with carcinogenic impurity by paying to Pharma companies? NeuroPharmac J. 2019; 4(3): 103-104. https://doi.org/10.37881/1.431
  22. Pathan A. Istradefylline: A new add-on drug to treat off episodes in adults with Parkinson’s disease. NeuroPharmac J. 2019; 4(2): 101-102. https://doi.org/10.37881/1.422
  23. Pathan A. Siponimod: A new approved oral drug to treat multiple sclerosis. NeuroPharmac J. 2019; 4(2): 99-100. https://doi.org/10.37881/1.421
  24. Pathan A. Stiripentol: New approved drug for the Dravet syndrome: Pharmacotherapeutics review. NeuroPharmac J. 2019; 4(1): 94-98. https://doi.org/10.37881/1.415
  25. Pathan A. Cannabidiol: FDA approved new drug for the Lennox-Gastaut syndrome and Dravet syndrome: Pharmacotherapeutics review. NeuroPharmac J. 2019; 4(1): 85-89. https://doi.org/10.37881/1.413
  26. Pathan A, Alshahrani A. FDA-approves the first therapy in 2018 for the seizures associated with Dravet syndrome. NeuroPharmac J. 2019; 4(1):81-84. https://doi.org/10.37881/1.412
  27. Pathan A, Almarshad F. Autism Spectrum Disorder: Medications overview. NeuroPharmac J. 2019; 4(1):77 80. https://doi.org/10.37881/1.411
  28. Alshahrani AM, Pathan A, Alruwais JF, Alduhayshi AM. Knowledge, attitude, and believes of epilepsy in local communities of Saudi Arabia. J Family Med Prim Care. 2019;8:1065-9. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6482760/
  29. Abdulaziz A. Alrashed, Khalid I. Aljammaz, Pathan A. Prevalence and risk factors of gastroesophageal reflux disease among Shaqra University students, Saudi Arabia.  J Family Med Prim Care. 2019;8:462-7. https://doi.org/10.4103/jfmpc.jfmpc_443_18
  30. Almarshad F, Ali A, Bakhsh E, Pathan A, Almegren A. Use of direct oral anticoagulants in daily practice. Am J Blood Res 2018;8(4):57-72. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6334188/
  31. Pathan A, Alshahrani AM. Possible management of non-motor symptoms of Parkinson’s Disease. NeuroPharmac J. 2018; 3(3): 69-76. https://doi.org/10.37881/1.332
  32. Pathan A, Alshahrani AM. Gold Standard of Symptomatic treatment in Parkinson disease: Carbidopa / Levodopa. NeuroPharmac J. 2018; 3(3): 63-68. https://doi.org/10.37881/1.331
  33. Pathan A,  Alshahrani A. Neuroprotective effects of Valeriana wallichii on scopolamine induced learning & memory impairment in rats. Pharmacognosy Journal. 2018; 10(6)Suppl:s38-s41. http://doi.org/10.5530/pj.2018.6s.7
  34. Pathan A, Alshahrani AM. Alzheimer’s disease: Pharmacotherapy of subjective cognitive decline. NeuroPharmac Journal. 2018; 3(2): 57-62. https://doi.org/10.37881/1.321
  35. Pathan A, Alshahrani AM. Alzheimer’s disease: Pharmacotherapy of non-cognitive symptoms. NeuroPharmac Journal. 2018; 3(1): 47-50. https://doi.org/10.37881/1.311
  36. Pathan A. Essential Tremor: β blockers a first-line therapy. NeuroPharmac J. 2017; 2(3): A1-A2. https://doi.org/10.37881/1.231
  37. Pathan A, Gautam V. Phytochemical Investigations of Indigenous herb: Curcuma caesia rhizomes. NeuroPharmac Journal. 2017; 2(2): 41-46. https://doi.org/10.37881/1.221
  38. Pathan A. Zika Virus: A threat to global Public health- WHO Faramework Review. NeuroPharmac J. 2016; 1(1):28-31. https://doi.org/10.37881/1.117
  39. Pathan A. Anethum graveolens seeds: Neurological assessment of anxiolytic like effect on albino mice by using locomotor activity. NeuroPharmac J. 2016;1(1):25-27. https://doi.org/10.37881/1.116
  40. Pathan A. Neurological assessment of antidepressant effect of seeds of Anethum graveolens on albino mice. NeuroPharmac J. 2016;1(1):22-24. https://doi.org/10.37881/1.115
  41. Pathan A, Gautam V. Peganum harmala seeds: evaluation of antiasthmatic effect by using Clonidine induced mast cell degranulation. NeuroPharmac Journal. 2016; 1(01): 18-21. https://doi.org/10.37881/1.114
  42. Pathan A, Gautam V, M Sabu. Evaluation of Antiasthmatic effect of Curcuma zedoaria rhizomes by using milk induced leukocytosis in mice. NeuroPharmac Journal. 2016; 1(01): 13-17. https://doi.org/10.37881/1.113
  43. Pathan A, Gautam V, M Sabu. Curcuma caesia rhizomes: evaluation of antiasthmatic effect by using clonidine induced mast cell degranulation. NeuroPharmac Journal. 2016; 1 (01): 07-12. https://doi.org/10.37881/1.112
  44. Pathan A, Alshahrani A. In vivo Neurological assessment of serotonergic response of Coriandrum sativum seeds in mice. International Journal of Research in Pharmacology & Pharmacotherapeutics. 2015; 4(04): 399-405. http://www.ijrpp.com/user/download/215/IJRPP_15_409%20_399-405.pdf
  45. Pathan A, Alshahrani A, Almarshad F. Middle East Respiratory Syndrome Coronavirus (MERS Co-V): Threat to global Public Health & challenges. International Journal of Research in Pharmacy and Chemistry. 2015; 5 (03): 434-438. http://www.ijrpc.com/files/09-07-15/09-5106.pdf
  46. Pathan A, Alshahrani A, Almarshad F. Neurological assessment of seeds of Coriandrum sativum by using Antidepressant and Anxiolytic like activity on albino mice. Inventi Impact: Ethnopharmacology. 2015; 5 (03): 102-105. Click here
  47. Pathan A, Alshahrani A, Almarshad F. World Health Organization Survey on Health Status of Saudi Arabia: A Review. Inventi Impact: Pharmacy Practice. 2015; 5 (03): 102-104. Click here
  48. Pathan A, Alshahrani A, Almarshad F. Pharmacological Effect of Curcuma zedoaria rhizomes on milk induced eosinophilia in the management of asthma. International Journal of Ethnobiology and Ethnomedicine. 2015; 1(01): 01-05. Click here
  49. Pathan A, Alshahrani A, Almarshad F. Protective Effect of Tridax Procumbens Linn Potential in Ulcerative Colitis by using Myeloperoxidase activity in Albino rats. Inventi Rapid: Ethnopharmacology. 2015; 5(01): 01-04. Click here
  50. Gautam PV, Pathan A, AK Singhai. Estrogenic activity of Bauhinia racemosa extract in Female albino rats: An Investigational study. Pharmacognosy Journal. 2014; 6(06): 05-09. https://doi.org/10.5530/pj.2014.6.2
  51. Pathan A, Alshahrani A,  Almarshad F. Histopathological evaluation of Tridax procumbens Linn potential in ulcerative colitis. Inventi Rapid: Ethnopharmacology. 2015; 5 (01): 01-06. Click here
  52. Pathan A, Gautam V. Ethnopharmacological evaluation of Curcuma caesia in management of asthma. Inventi Rapid: Ethnopharmacology. 2014; 4 (04): 01-04. Click here
  53. Pathan A, Gautam V. Pharmacological Investigations of Curcuma caesia in management of asthma. Inventi Rapid: Ethnopharmacology. 2014; 4 (04): 01-04. Click here
  54. Gautam V, Pathan A, Bharti UK, AK Singhai. Hypolipidemic activity of Viscum articulatum extracts in albino mice. Inventi Rapid: Ethnopharmacology. 2013; 3 (04): 01-03. Click here
  55. Pathan A, Gautam V, M Sabu. Curcuma caesia almost untouched drug: An updated ethnopharmacological review. Inventi Rapid: Planta Activa. 2013; 3 (04): 01-04. Click here
  56. Gautam V, Pathan A, AK Singhai. Characterization of Indigenous Traditional Medicine -Muktashukti Bhasma. Indian Journal of Traditional Knowledge. 2013; 12(4): 483-488. http://www.niscair.res.in/sciencecommunication/researchjournals/rejour/ijtk/ijtk0.asp
  57. Gautam V, Pathan A, Bharti UK, AK Singhai. Comparative in vitro antibacterial activity of ethanolic extract of Plumbago zeylenica. Indian Drugs. 2013; 50(04): 53-55. https://www.indiandrugsonline.org/issuesarticle-details?id=Mjk2
  58. Gautam V, Pathan A, Bharti UK, AK Singhai. Abutilons Indicum Linn: A Phytopharmacological Review. International Journal of Research in Pharmacy and Chemistry. 2013; 3 (1): 153-156. http://www.ijrpc.com/files/24-331.pdf
  59. Gautam V, Pathan A, Bharti UK, AK Singhai. Diplocyclos palmatus: A Phytopharmacological Review. International Journal of Research in Pharmacy and Chemistry. 2013; 3 (1): 157-159. http://www.ijrpc.com/files/25-336.pdf
  60. Gautam V, Pathan A, AK Singhai, Bharti UK, JC Hundiwale, Anti-stress and anti-allergic effect of Actiniopteris radiata in some aspects of Asthma. Pakistan Journal of Pharmaceutical Sciences. 2013; 26 (01): 195-198. http://www.pjps.pk/wp-content/uploads/pdfs/CD-PJPS-26-1-13/Paper-29.pdf
  61. Pathan A, Gautam V. Solanum xanthocarpum (white variety): A Phytopharmacological Review. International Journal of Pharmacy and Technology. 2012; 4(04): 2305-2310. https://www.ijptonline.com/wp-content/uploads/2009/10/2305-2310.pdf
  62. Pathan A, Gautam V, AK Singhai, Bharti UK. Peganum harmala: A Phytopharmacological Review. Inventi Rapid: Planta Activa. 2012; 2 (04): 01-02. Click here
  63. Gautam V. AK Singhai, Pathan A. Pharmacognostical and Phytochemical studies of Viscum articulatum Inventi Rapid: Planta Activa. 2012; 2 (03): 01-05. Click here
  64. Kishor AK, Pathan A, Nadeem L. Evaluation of in-vitro anticancer activity of fruit Lagenaria siceraria against MCF7, HOP62 and DU145 cell lines. International Journal of Pharmacy and Technology. 2011; 4(01): 3909-3924. https://www.ijptonline.com/wp-content/uploads/2009/10/3909-3924.pdf
  65. Pathan A, Kishor AK, Nadeem L. Analgesic and Anxiolytic activity of seeds of Coriandrum sativum International Journal of Research in Pharmacy and Chemistry. 2011; 1(04): 1087-1099. http://www.ijrpc.com/files/000042.pdf
  66.